These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19934646)

  • 21. Promoter methylation status of Ras-association domain family members in pheochromocytoma.
    Richter AM; Zimmermann T; Haag T; Walesch SK; Dammann RH
    Front Endocrinol (Lausanne); 2015; 6():21. PubMed ID: 25750636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer.
    Lee JJ; Geli J; Larsson C; Wallin G; Karimi M; Zedenius J; Höög A; Foukakis T
    Int J Oncol; 2008 Oct; 33(4):861-9. PubMed ID: 18813801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
    Guo J; Yang Y; Yang Y; Linghu E; Zhan Q; Brock MV; Herman JG; Zhang B; Guo M
    Oncotarget; 2015 Feb; 6(6):4202-13. PubMed ID: 25638156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent epigenetic inactivation of cystatin M in breast carcinoma.
    Schagdarsurengin U; Pfeifer GP; Dammann R
    Oncogene; 2007 May; 26(21):3089-94. PubMed ID: 17099723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.
    Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghavamzadeh A; Ghaffari SH
    Leuk Res; 2017 Oct; 61():33-38. PubMed ID: 28869817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
    Versmold B; Felsberg J; Mikeska T; Ehrentraut D; Köhler J; Hampl JA; Röhn G; Niederacher D; Betz B; Hellmich M; Pietsch T; Schmutzler RK; Waha A
    Int J Cancer; 2007 Aug; 121(3):547-54. PubMed ID: 17415710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RASSF proteins in cancer; from epigenetic silencing to functional characterization.
    Richter AM; Pfeifer GP; Dammann RH
    Biochim Biophys Acta; 2009 Dec; 1796(2):114-28. PubMed ID: 19344752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
    Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
    Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.
    Lal G; Padmanabha L; Smith BJ; Nicholson RM; Howe JR; O'Dorisio MS; Domann FE
    Cancer; 2006 Dec; 107(12):2752-9. PubMed ID: 17103461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma.
    Schagdarsurengin U; Gimm O; Dralle H; Hoang-Vu C; Dammann R
    Thyroid; 2006 Jul; 16(7):633-42. PubMed ID: 16889486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway.
    Fu J; Lv H; Guan H; Ma X; Ji M; He N; Shi B; Hou P
    BMC Cancer; 2013 Oct; 13():462. PubMed ID: 24098937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
    Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal RASSF family: RASSF7-RASSF10.
    Underhill-Day N; Hill V; Latif F
    Epigenetics; 2011 Mar; 6(3):284-92. PubMed ID: 21116130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.
    Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M
    Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
    Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
    Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
    Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.